FDA Inspection 1150180 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on August 13, 2021 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 13, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- San Antonio, TX (United States)